The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Prothromplex TOTAL 500 IU powder and solvent for solution for injection



Baxalta Innovations GmbHPA2004/005/002

Main Information

Trade NameProthromplex TOTAL 500 IU powder and solvent for solution for injection
Active SubstancesHuman coagulation factor ii
Human coagulation factor vii
Human coagulation factor ix
Human coagulation factor x
Human Protein C
Dosage FormPowder and solvent for solution for injection
Licence HolderBaxalta Innovations GmbH
Licence NumberPA2004/005/002

Group Information

ATC CodeB02BD01 coagulation factor IX, II, VII and X in combination

Status

License statusAuthorised
Licence Issued09/06/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back